CBD brand hires former FDA executive to oversee regulatory initiatives
North Carolina CBD maker cbdMD has hired Sibyl Swift, a former U.S. Food and Drug Administration official as a consultant to lead the company’s regulatory efforts and prepare products for certifications. Swift served in various roles at the FDA from 2014 to 2020, most notably as the associate director... Read more
Member Blog: As Cannabis Sales Rise, So Do Questions About Privacy and Security
Frank Nisemboum, Vice President of ERP Sales at c2b teknologies Legal cannabis is a big business that handles big data. From personalized data to protected health information to cannabis information that requires regulatory compliance with cybersecurity and data privacy laws–the entire cannabis industry faces data privacy and cybersecurity challenges... Read more
The importance of leveraging agricultural best practices, advanced breeding techniques, and region specific trailing data in hemp.
The importance of leveraging agricultural best practices, advanced breeding techniques, and region specific trailing data in hemp. Kola Seed, LLC is trialing and distributing premium hemp seed genetics to growers and processors, in 2021. Applying hemp trialing and market data, Kola Seed helps you source the best hemp seed... Read more
New USDA hemp rules: Find out what you need to know to succeed
The U.S. Department of Agriculture kicked off 2021 with the release of federal regulations that will govern hemp production going forward. Find out the key elements of the new rules with a free webinar with leading industry professionals who will provide an overview of what hemp operators need to... Read more
New Mexico judge repeals hemp regulations that revoked licenses without notice
A New Mexico district court has invalidated the state’s hemp production rules that allowed regulators to revoke or suspend licenses without notice and imposed strict testing requirements. Santa Fe District Court Judge Bryan Biedscheid said the New Mexico Department of Health’s rules were invalid because the agency failed to... Read more
Know before you grow: How to access certified hemp varieties
In the two years since hemp became a legal commercial crop in the United States, producers’ challenges in sourcing a consistent supply of predictable, reliable genetics haven’t subsided, as the industry establishes itself and plant-breeding efforts continue. Growers looking to source reliable hemp genetics may consider looking at seed... Read more
AOSCA review board clears 4 new CBD-dominant seeds
A publicly traded California biotech company announced Tuesday that four of its hemp seed varieties have been aproved by the national variety board of the Association of Official Seed Certifying Agencies. Davis-based Arcadia Biosciences received eligibility for certified seed production for its GoodHemp brand varieties including Rogue, Umpqua, Santiam... Read more
Protected: #IndustryEssentials Recording – Catalyst Conversations | 2.2.21 | 2021 Cannabis Industry Business Opportunities
#IndustryEssentials Recording – Catalyst Conversations | 2.2.21 | 2021 Cannabis Industry Business Opportunities | Education NCIA is leading the cannabis industry’s unified and coordinated campaign to ensure our business sector is treated fairly and has the opportunity to reach its full potential. Now – more than ever – is... Read more
Hemp in the Biden administration: Optimism and uncertainty
The hemp industry has high hopes for thriving under President Joe Biden, with operators seeing opportunities in the president’s climate plan and feeling optimistic that congressional action on high-THC cannabis will open more opportunities for hemp entrepreneurs. But the industry is still waiting for answers on some of its... Read more
CBD maker GW Pharma agrees to $7.2 billion acquisition by Ireland’s Jazz Pharmaceuticals
(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )